Kakkar V V, Stamatakis J D, Bentley P G, Lawrence D, de Haas H A, Ward V P
JAMA. 1979 Jan 5;241(1):39-42.
Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium, or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with iodine 125; in patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The data indicate that the combination of dihydroergotamine and heparin is more effective than heparin or dihydroergotamine alone in preventing DVT.
对300例接受腹部大手术或髋关节置换术的患者进行了随机临床试验,以研究甲磺酸双氢麦角胺、肝素钙或甲磺酸双氢麦角胺与肝素联合使用在预防术后深静脉血栓形成(DVT)方面的疗效。DVT的诊断通过使用碘125标记的纤维蛋白原摄取试验来确定;在接受髋关节置换术的患者中,还采用静脉造影来确认或排除同位素血栓的存在。数据表明,甲磺酸双氢麦角胺与肝素联合使用在预防DVT方面比单独使用肝素或甲磺酸双氢麦角胺更有效。